|
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study |
|
|
|
Titel: |
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study |
Auteur: |
Deng, Li-Juan Zhou, Ke-Shu Liu, Li-Hong Zhang, Ming-Zhi Li, Zhi-Ming Ji, Chun-Yan Xu, Wei Liu, Ting Xu, Bing Wang, Xin Gao, Su-Jun Zhang, Hui-Lai Hu, Yu Li, Yan Cheng, Ying Yang, Hai-Yan Cao, Jun-Ning Zhu, Zun-Min Hu, Jian-Da Zhang, Wei Jing, Hong-Mei Ding, Kai-Yang Zhang, Xiang-Yang Zhao, Ren-Bin Zhang, Bin Tian, Ya-Min Song, Yong-Ping Song, Yu-Qin Zhu, Jun |
Verschenen in: |
Blood advances |
Paginering: |
Jaargang 7 () nr. 16 pagina's 4349-4357 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
The American Society of Hematology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|